Successful Treatment of Multifocal Histiocytic Sarcoma Occurring after Renal Transplantation with Cladribine, High-Dose Cytarabine, G-CSF, and Mitoxantrone (CLAG-M) Followed by Allogeneic Hematopoietic Stem Cell Transplantation

Table 1

CLAG-M regimen as administered to patient
Cladribine	5 mg/m^2/day IV days 2–6
Cytarabine	2,000 mg/m^2/day IV days 2–6
Mitoxantrone	10 mg/m^2/day IV days 2–4
G-CSF	480 mcg/day SC days 1–6

Cladribine, high-dose cytarabine, G-CSF, and mitoxantrone (CLAG-M) (IV = intravenous; SC = subcutaneous).